NASDAQ trade advice (B): US biotechnology stock | 6-8% gain | USA stock trading signal on 16 Oct 2024

Stock Market
NASDAQ, United States of America

Target hit. Trade closed.

16 Oct 2024
18 Oct 2024
18 Oct 2024
3 days
Loss per
100,000 USD
Stop-loss
43.75
Buy Advice
16 Oct 2024
45.5 – 46.5
Target 1
18 Oct 2024
49.5
Target 2
18 Oct 2024
50
Profit per
100,000 USD
3 days
8,696
43.75
45.5 – 46.5
49.5
50
8,696
  • Buy
  • Buy
    Range
  • Target
  • Stoploss
  • Upside
    Potential
  • Trade
    Duration
  • Corcept Therapeutics
  • 45.5 – 46.5
  • 49.5 – 50
  • Below 43.75
  • 6% – 8%
  • 12 - 14 Days
  • Buy Corcept Therapeutics
  • Buy
    Range
    45.5 – 46.5
  • Target 49.5 – 50
  • Stoploss Below 43.75
  • Upside
    Potential
    6% – 8%
  • Trade
    Duration
    12 - 14 Days
  • * Once the first target hit, reset the StopLoss at your buying price.
    * Trade durations are approximate; actual holding period may vary.

    Corcept Therapeutics (NASDAQ: CORT) - Stock Overview

  • NASDAQ code
  • Stock Name
  • Sector
  • 52 Weeks High
  • 52 Weeks Low
  • CORT
  • Corcept Therapeutics
  • Biotechnology
  • 47.71
  • 20.84
  • NASDAQ code CORT
  • Stock Name Corcept Therapeutics
  • Sector Biotechnology
  • 52 Weeks High 47.71
  • 52 Weeks Low 20.84
  • Company profile

    Corcept Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for severe endocrine, oncologic, and metabolic disorders. Their lead product, Korlym, is approved for Cushing’s syndrome, a rare endocrine condition. Corcept is also advancing several pipeline candidates, including relacorilant for Cushing’s syndrome, treatments for various cancers, and potential therapies for neurological conditions like amyotrophic lateral sclerosis and nonalcoholic steatohepatitis. Founded in 1998, Corcept is based in Menlo Park, California.

  • Corcept Therapeutics (NASDAQ: CORT) vs NASDAQ - Relative Strength Comparison

    The image showcases Corcept Therapeutics's 1-year performance relative to NASDAQ.
    Relative Performance - Last 1 Year
    CORT —   NASDAQ —

  • Corcept Therapeutics (NASDAQ: CORT) - Technical Analysis (Daily)

    Corcept Therapeutics - Technical Analysis chart on Daily Price and Volume
    Corcept Therapeutics - Technical Analysis chart on Daily Price and Volume

    • After an extended period of consolidation, the stock price has formed an Inverted Head & Shoulders pattern.
    • After breaking out, the stock has settled above the breakout level and then jumped higher.
    • A bullish Pole & Flag pattern is now visible on the chart, and with the recent breakout, the stock price is aiming for new highs.
  • Corcept Therapeutics (NASDAQ: CORT) - RSI Indicator

    Corcept Therapeutics stock analysis based on RSI indicator
    Corcept Therapeutics - RSI indicator

    • Current RSI of this stock is 69.31, which indicates the strength of buyers.

  • Corcept Therapeutics (NASDAQ: CORT) - ADX & DI Indicator

    Corcept Therapeutics stock analysis based on ADX & DI indicator
    Corcept Therapeutics - ADX & DI indicator

    • Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.

  • Corcept Therapeutics (NASDAQ: CORT) - EMA Crossover

    Corcept Therapeutics stock analysis based on EMA Crossover
    Corcept Therapeutics - EMA Crossover

    • The short length exponential moving average (10 EMA) has crossed the long length exponential moving average (20 EMA) from the below, generates bullish signal. Last day’s candle has closed above all these moving averages. This suggests buyers are taking interest in this stock.

  • Conclusion - Corcept Therapeutics (NASDAQ: CORT) Stock Price Forcast

    Based on our stock trading picks in US, Corcept Therapeutics stock price target will be USD 49.5 - USD 50 in the next 12-14 trading sessions.

  • Share with
    0 0 votes
    Article Rating
    Subscribe
    Notify of
    guest
    0 Comments
    Inline Feedbacks
    View all comments

    Join Our Telegram Channel for US Stock Market Update

    USA Stock Analysis

    The stock trading advice is prepared by the Naranj Capital team under the guidance of Arijit Banerjee, CMT, CFTe.
    Maximize your return with our precise trading advice on the USA stock exchange! We recommend an technology stock poised for
    Get expert short-term trading advice for the USA stock exchange. This energy stock is projected to deliver 5%-6% returns in
    Short Term Trading Alert: This Consumer Discretionary stock has the upside potential of 5-6% in 14-15 trading days. Swing Trading
    Short Term Trading Advice: Qualcomm Inc (NASDAQ - QCOM) has the upside potential of 5-6% in 14-15 trading days

    Join Our Telegram Channel for Saudi Stock Market Update

    Saudi Stock Analysis

    Maximize your return with our precise trading advice on Saudi stock exchange Tadawul! We recommend buying Arabian Pipes (Tadawul 2200)
    Short Term Trading Alert: This Saudi health care equipment stock has the upside potential of 8-10% in 12-14 trading days.
    Get expert short-term trading advice for the Saudi stock exchange Tadawul. Buy Etihad Atheeb Telecom (Tadawul 7040) for 13%-16% returns
    Short term trading advice for Shariah compliant Tadawul stocks. Buy Riyadh Cables Group (Tadawul 4142) with potential for 15-17% returns
    Maximize your trading returns in Saudi stock exchange Tadawul! Discover a shariah halal materials sector stock having 7-9% gains in
    Details of Arijit Banerjee

    Arijit Banerjee CMT CFTe is a seasoned expert in the financial industry, boasting decades of experience in trading, investment, and wealth management. As the founder and chief strategist of Naranj Capital, he’s built a reputation for providing insightful research analysis to guide investment decisions.

    Arijit’s credentials are impressive, holding both the Chartered Market Technician (CMT) and Certified Financial Technician (CFTe) designations. These certifications demonstrate his expertise in technical analysis and financial markets.

    Through Naranj Capital, Arijit shares his market insights and research analysis, offering actionable advice for investors. His work is featured on platforms like TradingView, where he publishes detailed analysis and recommendations.

    If you’re interested in learning more about Arijit’s work or Naranj Capital’s services, you can reach out to them directly through their website